Sanofi agrees to buy U.S. mRNA partner Translate Bio in $3.2 billion deal

Sanofi agrees to buy U.S. mRNA partner Translate Bio in $3.2 billion deal

Source: 
CNBC
snippet: 
  • Sanofi, Translate Bio developing potential COVID-19 vaccine     
  • Offering $38/share for Translate Bio     
  • Offer gives Translate Bio a $3.2 billion equity value